AXOGEN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.27 USD | +2.62% |
|
+3.81% | -8.20% |
| 05-16 | AxoGen Initiates Rolling Submission to FDA For Avance Nerve Graft | MT |
| 05-02 | Transcript : AxoGen, Inc., Q1 2024 Earnings Call, May 02, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Advanced Medical Equipment & Technology
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 274M | - | - | - | |||
| 223B | ||||||
| 195B | ||||||
| 144B | ||||||
| 111B | ||||||
| 65.01B |
- Stock Market
- Equities
- AXGN Stock
- Charts AxoGen, Inc.
- Sector Chart
